Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year-Reference-Cited by-同舟云学术

Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year

Published:2013-08-20 Issue:2 Volume:231 Page:357-366
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Crespo-Facorro Benedicto,Ortiz-Garcia de la Foz Victor,Mata Ignacio,Ayesa-Arriola Rosa,Suarez-Pinilla Paula,Valdizan Elsa M.,Martinez-Garcia Obdulia,Pérez-Iglesias Rocío

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-013-3241-3.pdf

Reference32 articles.

1. Abdel-Baki A, Ouellet-Plamondon C, Malla A (2012) Pharmacotherapy challenges in patients with first-episode psychosis. J Affect Disord 138(Suppl):S3–S14

2. Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry (Suppl) 22:39–44

3. Andreasen NC (1983) Scale for the assessment of negative symptoms (Sans). University of Iowa, Iowa

4. Andreasen NC (1984) Scale for the assessment of positive symptoms (Saps). University of Iowa, Iowa

5. Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review;International Clinical Psychopharmacology;2024-06-14

2. Antipsychotic drugs in first-episode psychosis: a target trial emulation in the FEP-CAUSAL Collaboration;American Journal of Epidemiology;2024-04-03

3. Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis;Pharmacy;2023-11-10

4. Ziprasidone, Zuclopenthixole, and Fluspirilene in the Treatment of Psychosis;NeuroPsychopharmacotherapy;2022

5. The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients;Toxins;2021-11-18